Medical device company AtriCure, Inc. has established a strong presence in the cardiac ablation market, selling its radio frequency products and ablation systems to medical centers around the world. The company's product offerings include Isolator Synergy Clamps, a line of disposable radio frequency products, as well as multifunctional pens and linear ablation devices such as the MAX Pen device, which can evaluate cardiac arrhythmias, perform temporary cardiac pacing and stimulate and ablate cardiac tissue all in one. AtriCure's Coolrail device allows for longer linear lines of ablation, while the cryoICE Cryoablation System and EPi-Sense Guided Coagulation System help treat atrial fibrillation. AtriCure also offers an implantable AtriClip System and LARIAT System for soft-tissue closure. The company sells its products through independent distributors and direct sales personnel, and is headquartered in Mason, Ohio after being founded in 2000.
AtriCure's ticker is ATRC
The company's shares trade on the NASDAQ stock exchange
They are based in Mason, Ohio
There are 501-1000 employees working at AtriCure
It is atricure.com/about-atricure
AtriCure is in the Healthcare sector
AtriCure is in the Medical Instruments & Supplies industry
The following five companies are AtriCure's industry peers: